Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.52 |
| ▸ | CHRM4 known ✓ | P08173 | 1/20 | 0.52 |
| ▸ | CHRM5 known ✓ | P08912 | 1/20 | 0.52 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.52 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.52 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.41 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 6/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | TP53 | P04637 | 3/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.52 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27625043 | 0.98 | TSHR (0.52) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Hydrochloric Acid SCHEMBL28216348 | 0.98 | TSHR (0.52) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Trimethylammonium SCHEMBL29043998 | 0.98 | TSHR (0.52) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL15115 | 0.98 | TSHR (0.56) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Methylamine SCHEMBL18250065 | 0.96 | TSHR (0.50) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Ethylene SCHEMBL8397415 | 0.96 | TSHR (0.54) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Ammonia Solution, Strong SCHEMBL1399858 | 0.96 | TSHR (0.54) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Iodide SCHEMBL1254059 | 0.96 | TSHR (0.54) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL28612529 | 0.96 | TSHR (0.54) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| Fluoride SCHEMBL1255037 | 0.96 | TSHR (0.54) | TSHRALDH1A1TP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 907 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739418-A2 | ONE-PASS DEOXYGENATION METHOD FOR POLYACRYLAMIDE PRODUCTION | KEMIRA OYJ (FI) | 2026-05-13 | — | — | EP | claimed |
| EP-4728136-A1 | STRENGTH SYNERGY BETWEEN POLYMER AND PAPERMAKING STRENGTH AID | Ecolab USA, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4716777-A2 | USE OF AMPHOTERIC EMULSION POLYMERS WITH STRENGTH RESINS AS RETENTION AND DRAINAGE AIDS | KEMIRA OYJ (FI) | 2026-04-01 | — | — | EP | claimed |
| US-12553188-B2 | GPAM compositions and methods | KEMIRA OYJ (FI) | 2026-02-17 | — | — | US | claimed |
| EP-4683950-A1 | DUAL EMULSIFICATION OF ALKENYL SUCCINIC ANHYDRIDE TO IMPROVE SIZING PERFORMANCE AND STABILITY | KEMIRA OYJ (FI) | 2026-01-28 | — | — | EP | claimed |
| US-20250215649-A1 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYSACCHARIDE PROMOTER | KEMIRA OYJ (FI) | 2025-07-03 | — | — | US | claimed |
| CN-115516031-B | GPAM compositions and methods | 凯米拉公司 | 2025-06-17 | — | — | CN | claimed |
| CN-119931618-A | Fluid loss agent and preparation method thereof | 中国石油天然气集团有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-20250137200-A1 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYMERIC PROMOTER | KEMIRA OYJ (FI) | 2025-05-01 | — | — | US | claimed |
| EP-4256009-B1 | OIL-IN-WATER EMULSIONS | QUADRISE INT LTD (GB) | 2025-04-09 | — | — | EP | claimed |
| US-20040062791-A1 | Ion triggerable, cationic polymers, a method of making same and items using same | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-04-01 | — | — | US | claimed |
| US-20040063888-A1 | Ion triggerable, cationic polymers, a method of making same and items using same | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-04-01 | — | — | US | claimed |
| WO-2004026351-A2 | IMPROVED ION TRIGGERABLE, CATIONIC POLYMERS, A METHOD OF MAKING SAME AND ITEMS USING SAME | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2004-04-01 | — | — | WO | claimed |
| WO-2004026354-A1 | ION TRIGGERABLE, CATIONIC POLYMERS, A METHOD OF MAKING SAME AND ITEMS USING SAME | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2004-04-01 | — | — | WO | claimed |
| WO-2004026958-A1 | IMPROVED ION TRIGGERABLE, CATIONIC POLYMERS, A METHOD OF MAKING SAME AND ITEMS USING SAME | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2004-04-01 | — | — | WO | claimed |
| WO-2004026352-A1 | USE AS BINDER OF ION TRIGGERABLE, VINYL-BASED CATIONIC POLYMERS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2004-04-01 | — | — | WO | claimed |
| US-20040058606-A1 | Ion triggerable, cationic polymers, a method of making same and items using same | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-03-25 | — | — | US | claimed |
| US-20040055704-A1 | Ion triggerable, cationic polymers, a method of making same and items using same | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-03-25 | — | — | US | claimed |
| EP-0139588-B1 | AMPHOLYTIC CATIONIC TETRAPOLYMERS, THEIR USE IN THE TREATMENT OF KERATIN FIBRES AND COMPOSITIONS CONTAINING THEM | SOCIETE FRANCAISE HOECHST Société anonyme dite: (FR) | 1987-07-01 | — | — | EP | claimed |
| US-4590249-A | ACRYLAMIDE, 2-ACRYLAMIDO-2METHYL PROPANE SULFONIC ACID, AMINE SUBSTITUTED UNSATURATED ESTER OR AMIDE AND QUATERNARY AMINE SALT THEREOF | SOCIETE FRANCAISE HOECHST (FR) | 1986-05-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040062791-A1 | Ion triggerable, cationic polymers, a method of making same and items using same | PWWP2B, DSG1, WDR1 | CHRM2 2205/4885CHRM4 1991/4885CHRM5 2978/4885 |
| US-12553188-B2 | GPAM compositions and methods | PGM2, SLC6A9, GNMT | CHRM2 680/4885CHRM4 1432/4885CHRM5 1217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.